Page last updated: 2024-10-23

bromhexine and Ciliary Motility Disorders

bromhexine has been researched along with Ciliary Motility Disorders in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Ciliary Motility Disorders: Conditions caused by abnormal CILIA movement in the body, usually causing KARTAGENER SYNDROME, chronic respiratory disorders, chronic SINUSITIS, and chronic OTITIS. Abnormal ciliary beating is likely due to defects in any of the 200 plus ciliary proteins, such as missing motor enzyme DYNEIN arms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lunichkina, IV1
Solopov, VN1

Other Studies

1 other study available for bromhexine and Ciliary Motility Disorders

ArticleYear
[Peroral therapy with expectorants].
    Klinicheskaia meditsina, 1988, Volume: 66, Issue:12

    Topics: Administration, Oral; Ambroxol; Bromhexine; Ciliary Motility Disorders; Expectorants; Humans; Lung D

1988